Otitis Media

Bacterial Colonization and Inflammatory Cascade

Middle Ear Pressure Dynamics and Otalgia

Immune Response Variables Affecting Disease Severity

Bacterial Pathogens and Serotype Distribution

• Streptococcus pneumoniae (30-50% of culture-confirmed AOM): Encapsulated gram-positive cocci; antibiotic susceptibility varies by serotype and penicillin/cephalosporin MIC; serotypes 6, 14, 19, 23 predominate in AOM. Post-PCV7 and PCV13 era has seen shift toward non-vaccine serotypes (especially 19A) with enhanced beta-lactam resistance.
• Nontypeable Haemophilus influenzae (20-30%): Gram-negative coccobacillus; produces beta-lactamase in 30-50% of isolates, conferring ampicillin resistance; often beta-lactamase negative, ampicillin-resistant (BLNAR) strains emerging.
• Moraxella catarrhalis (10-15%): Gram-negative diplococcus; >90% produce beta-lactamase; typically susceptible to fluoroquinolones and macrolides.

Eustachian Tube Dysfunction Risk Factors

• Adenoid hypertrophy: Lymphoid tissue in nasopharynx obstructs ET opening; peak incidence 4-7 years; responsible for 30-40% of recurrent AOM cases in this age group.
• Allergic rhinitis: Chronic eosinophilic inflammation of nasal mucosa and ET; IgE-mediated mast cell degranulation perpetuates mucosal edema.
• Chronic rhinosinusitis: Sustained nasopharyngeal inflammation provides persistent bacterial reservoir and ET obstruction.
• Cleft palate: Abnormal insertion or tension of tensor veli palatini muscle impairs active ET opening; affects up to 90% of children with unrepaired palate.
• Down syndrome and other syndromic conditions: Associated with anatomic ET abnormalities; hypotonia of ET muscles; immune dysfunction.

Epidemiologic and Host Risk Factors

• Age 6-24 months: Peak incidence correlates with maximum ET compliance and vulnerability; by age 7-8 years, incidence declines as temporal bone pneumatization and ET muscularization improve.
• Male gender: 1.3-1.5× higher incidence in boys; possibly related to differences in immune response or ET anatomy.
• Daycare attendance: 2-3× increased risk due to exposure to respiratory pathogens and bacterial colonization with more virulent strains; risk correlates with group size.
• Second-hand smoke: Impairs mucociliary function and promotes nasopharyngeal inflammation; increases risk 1.5-2.0×.
• Lack of breastfeeding: Breast milk provides secretory IgA, lysozyme, and lactoferrin; breastfed infants have 30-40% lower AOM risk.
• Premature birth and low birth weight: Immature immunity; higher incidence of concurrent URI and bacterial colonization.
• Immunodeficiency (primary or secondary): Hypogammaglobulinemia, complement deficiencies, HIV infection; associated with severe, recurrent infections.
• Recurrent AOM definition: ≥3 AOM episodes in 6 months or ≥4 in 12 months; affects 5-10% of children; often multifactorial (ET dysfunction, frequent URI exposure, bacterial virulence factors, suboptimal immune response).

Cardinal Symptom: Otalgia (Ear Pain)

Systemic Symptoms

• Fever: Present in 50-80% of AOM cases; typically low-grade (38.0-39.0°C) but can reach 40°C or higher in severe infections; correlates with bacterial pathogen virulence and host immune activation rather than disease severity.
• Upper respiratory symptoms: Concurrent rhinitis, pharyngitis, or cough (present in 70-80%) reflects the URI trigger; nasal congestion and drainage commonly precede ear symptoms.
• Gastrointestinal symptoms: Nausea, vomiting, and diarrhea occur in 10-20% of cases, particularly in infants; thought to represent referred symptoms or response to systemic inflammation rather than direct GI involvement.
• Behavioral changes: Irritability, lethargy, or altered consciousness should raise concern for meningitis or other complications.

Physical Examination Findings

• Otoscopic findings - Tympanic membrane changes:
• Erythema: Hyperemia of the tympanum indicates inflammation; diffuse erythema is suggestive of AOM, though mild erythema alone (especially if circumscribed) may occur in fever from other causes or with crying.
• Opacification/Loss of translucency: The normal tympanum is translucent with visible bony landmarks (malleus, incus, stapes footplate). In AOM, mucopurulent effusion behind the drum causes it to appear dull or opaque; this is one of the most sensitive findings for middle ear effusion.
• Convexity/Bulging: Increased intratympanic pressure causes outward bulging of the tympanum, obliterating the normal concave contour; bulging is a reliable indicator of significant pressure and increased risk of spontaneous perforation.
• Air-fluid level or air-bone interface: When present, creates a horizontal line across the drum or a meniscus appearance (seen best with pneumatic otoscopy); highly specific for OME.
• Perforation: Visible discontinuity in the membrane; usually central; may be small (pinpoint) or large; purulent drainage visible in the canal.
• Loss of light reflex: Normally a sharp cone of light is reflected from the anterior-inferior tympanum; effusion and inflammation dull or eliminate this landmark.

• Pneumatic otoscopy findings: Application of gentle positive and negative pressure via pneumatic otoscope bulb demonstrates reduced or absent tympanic membrane mobility in middle ear effusion (sensitivity ~80-90% for effusion detection). Normal tympanum shows visible movement with pressure changes; immobility suggests fluid accumulation or high intratympanic pressure.

• Weber and Rinne tuning fork tests:
• In AOM/OME, conductive hearing loss occurs (bone conduction > air conduction); Weber test shows lateralization to affected ear, and Rinne shows bone conduction better than air conduction on affected side.
• In infants and young children, formal tuning fork testing is often impractical; behavioral audiometry or tympanometry preferred.

• Otoscopic findings of complications:
• Postauricular swelling, erythema, and tenderness suggest mastoiditis (infection of mastoid bone air cells).
• Meningismus (neck stiffness, positive Kernig/Brudzinski signs) indicates possible meningeal involvement.
• Facial nerve paralysis suggests malignant external otitis or Ramsay Hunt syndrome (though rare complications in typical AOM).

Clinical Variants and Presentations

• Acute Otitis Media with Spontaneous Perforation: Sudden onset of purulent drainage from ear canal with immediate pain relief; may be preceded by severe otalgia. Parents often report blood-tinged or purulent drainage on bedding or clothing.

• Otitis Media with Effusion (OME): Often asymptomatic or presenting with mild hearing loss, speech delay, or balance difficulties; typically follows AOM by 2-4 weeks; can persist for months.

• Otitis Media in Infants <3 Months: May present with nonspecific signs (fever, irritability, poor feeding, vomiting) without prominent otalgia; high risk for concurrent bacteremia or meningitis; lower diagnostic certainty due to difficulty with otoscopy in this age group.

• Recurrent Acute Otitis Media (RAOM): Recurrent distinct episodes of AOM separated by symptom-free intervals; contrasts with chronic suppurative otitis media or persistent OME.

Diagnostic Criteria for Acute Otitis Media (American Academy of Pediatrics)

1. 1.Acute onset of signs and symptoms (within 48 hours)
2. 2.Middle ear effusion, evidenced by any of: (a) otoscopic findings of bulging tympanum or air-fluid level; (b) tympanometry showing Type B or C curve (see below); (c) absent tympanic membrane mobility on pneumatic otoscopy
3. 3.Signs of acute middle ear inflammation, demonstrated by: (a) ear pain (or other symptom referable to ear) or significant fever ≥38.0°C (≥100.4°F); (b) marked erythema of tympanic membrane (diffuse and bright red); (c) purulent otorrhea

Otoscopy - Gold Standard Diagnostic Tool

• Use largest speculum that fits the canal without causing discomfort
• Insert slowly at an angle to visualize the entire tympanum (posterosuperior, posteroinferior, anterosuperior, anteroinferior quadrants)
• Perform in well-lit setting (otoscope with halogen or LED light)
• Apply gentle positive and negative pressure with pneumatic bulb to assess membrane mobility
• Document findings systematically (location, degree of erythema, membrane contour, presence of effusion signs)
• In uncooperative toddlers, parent positioning, restraint, or sedation may be necessary for adequate visualization

Tympanometry - Objective Assessment of Middle Ear Function

• Type A curve (normal): Peak compliance at ambient pressure (0 daPa); indicates normal middle ear function; argues against significant effusion.
• Type B curve (flat): Reduced compliance across all pressures; indicates middle ear effusion (fluid prevents pressure equalization) or TM perforation; highly specific for effusion (sensitivity 80-90%).
• Type C curve (shifted left): Peak compliance at negative pressure (typically -100 to -200 daPa); indicates ET dysfunction with negative middle ear pressure; supports diagnosis of OME or early AOM.
• Type As curve (shallow A peak)

Symptom control comes first (all patients)

• Analgesia: acetaminophen or ibuprofen is indicated regardless of whether antibiotics are given — the AAP 2013 AOM guideline treats pain management as a mandatory, separate decision from antimicrobial therapy. Topical benzocaine drops are optional and only for an intact tympanic membrane.

Antibiotics versus watchful waiting (AAP 2013)

• Treat immediately: any child <6 months; any child with severe disease (moderate-to-severe otalgia, otalgia ≥48 hours, or temperature ≥39°C); otorrhea from AOM; and bilateral AOM in children 6–23 months.
• Observation option: nonsevere unilateral AOM at 6–23 months, and nonsevere unilateral or bilateral AOM at ≥24 months — only with assured follow-up and a plan to start antibiotics if no improvement in 48–72 hours.

First-line therapy

• Aminopenicillin — high-dose amoxicillin (80–90 mg/kg/day divided BID): the high dose overcomes penicillin-binding-protein alterations in intermediate-resistant S. pneumoniae, the pathogen most likely to cause suppurative complications.
• Beta-lactam/beta-lactamase inhibitor — amoxicillin-clavulanate: first-line instead if amoxicillin was taken within 30 days, if there is concurrent purulent conjunctivitis (the otitis-conjunctivitis syndrome of nontypeable H. influenzae), or with recurrent AOM unresponsive to amoxicillin — clavulanate covers beta-lactamase–producing H. influenzae and M. catarrhalis.

Penicillin allergy and escalation

• Cephalosporins (cefdinir, cefpodoxime, cefuroxime): appropriate for non-anaphylactic penicillin allergy; true cross-reactivity is roughly 1–3% and is driven by shared R1 side chains, not the beta-lactam ring itself.
• Ceftriaxone IM/IV: for vomiting, nonadherence, or failure of amoxicillin-clavulanate (given as a short course, typically up to 3 days).
• Failure after ceftriaxone: consider tympanocentesis for culture ± clindamycin for multidrug-resistant pneumococcus; ENT referral.
• Duration: 10 days if <2 years or severe; shorter courses (5–7 days) are acceptable in older children with nonsevere disease.

Surgical/definitive

• Tympanostomy tubes: per AAO-HNS, for recurrent AOM with effusion present between episodes, or bilateral OME persisting ≥3 months with hearing loss. Tube otorrhea is treated with topical fluoroquinolone drops, not oral antibiotics.

Avoid

• Antihistamines and decongestants: no benefit in AOM or OME and carry adverse effects (AAP).
• Macrolides and TMP-SMX: high pneumococcal resistance; reserve only when no alternative exists.
• Ototoxic aminoglycoside drops: contraindicated with a perforated drum or patent tube.

Intratemporal (extracranial)

• Tympanic membrane perforation: intratympanic pressure exceeds membrane tensile strength; signaled by abrupt pain relief with purulent otorrhea. Most heal spontaneously; failure to close leads to chronic suppurative otitis media (painless otorrhea >6 weeks through a persistent perforation).
• Acute mastoiditis: spread of suppuration through the aditus ad antrum into mastoid air cells with bony coalescence. Look for postauricular erythema, fluctuant swelling, tenderness, and an auricle displaced outward and downward. Emergency — obtain CT of the temporal bone, admit for IV antibiotics, and consult ENT for possible mastoidectomy.
• Cholesteatoma: chronic negative pressure creates a retraction pocket that traps keratinizing squamous epithelium, which secretes collagenases and erodes ossicles. Signaled by painless, foul-smelling otorrhea with a pearly white mass or granulation tissue; progressive conductive loss. Requires surgical excision.
• Labyrinthitis: inflammation crossing the round window; vertigo, nystagmus, and sensorineural hearing loss.
• Facial nerve palsy: CN VII traverses the middle ear in a dehiscent fallopian canal; ipsilateral peripheral palsy mandates urgent drainage/myringotomy plus antibiotics.
• **Petrous apicitis (Gradenigo syndrome): the triad of otorrhea, deep retro-orbital pain (CN V), and CN VI palsy with diplopia. Emergency.**
• Hearing loss and speech/language delay: conductive loss from persistent effusion during the critical language window — the main driver of tube placement.

Intracranial (all emergencies)

• Meningitis: the most common intracranial complication; fever, meningismus, altered mental status — LP after imaging if focal signs.
• Brain abscess (temporal lobe or cerebellum) and epidural/subdural empyema: focal deficits, seizure, ring-enhancing lesion on contrast MRI.
• Lateral/sigmoid sinus thrombosis: septic thrombophlebitis; picket-fence fevers, headache, papilledema, sometimes Griesinger sign (postauricular edema over the mastoid emissary vein).

Treatment-related

• Aminopenicillin adverse effects: diarrhea (worse with clavulanate), morbilliform rash, and the classic near-universal rash when an aminopenicillin is given during acute EBV infection — not a true IgE allergy.
• Antibiotic complications: C. difficile colitis, acute interstitial nephritis, ceftriaxone biliary sludging.
• Tympanostomy tube sequelae: recurrent otorrhea, tube occlusion or premature extrusion, tympanosclerosis, and persistent perforation after extrusion.

• A bulging, opaque tympanic membrane with impaired mobility is the single most specific finding. Erythema alone in a crying, febrile child is the classic distractor — without effusion there is no AOM.
• High-dose amoxicillin is the answer unless a specific exception is present. The three exceptions worth memorizing: amoxicillin within 30 days, concurrent purulent conjunctivitis, or amoxicillin failure — all point to amoxicillin-clavulanate.
• **Purulent conjunctivitis plus AOM = nontypeable *Haemophilus influenzae*** (otitis-conjunctivitis syndrome). This is the association examiners test most reliably.
• Watchful waiting is a correct answer for nonsevere unilateral AOM in a child ≥6 months (and either ear at ≥24 months) when follow-up is assured (AAP). Do not reflexively pick an antibiotic; but always pick an analgesic.
• Postauricular swelling with an anteriorly and inferiorly displaced auricle = mastoiditis. Best next step is CT of the temporal bone with IV antibiotics and ENT consultation — not oral antibiotics and outpatient follow-up.
• ***Painless, chronically foul-smelling otorrhea* with a pearly mass or granulation tissue = cholesteatoma**, which is surgical. Contrast with the sudden relief of pain plus purulent drainage that signals simple perforation.
• A flat (Type B) tympanogram means effusion or perforation, not necessarily infection. Persistent bilateral effusion ≥3 months with documented hearing loss is the trigger for tympanostomy tubes and formal audiometry (AAO-HNS/AAP).
• Fever <28 days of life or ill appearance changes the whole algorithm — young infants with fever need a full sepsis evaluation rather than being labeled with AOM alone.
• Common pharmacology distractors: antihistamines/decongestants (no benefit, AAP), macrolides (pneumococcal resistance), and ototoxic aminoglycoside drops with a perforated drum. Also remember that a rash after amoxicillin in a teen with pharyngitis and lymphadenopathy suggests EBV, not penicillin allergy.